Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Tax Provisions (2024 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Tax Provisions for 2 consecutive years, with -$643128.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Tax Provisions changed N/A year-over-year to -$643128.0, compared with a TTM value of $1.5 million through Sep 2025, changed N/A, and an annual FY2024 reading of $2.1 million, up 2225.09% over the prior year.
  • Tax Provisions was -$643128.0 for Q3 2025 at Kiora Pharmaceuticals, down from -$112057.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $2.1 million in Q4 2024 and bottomed at -$643128.0 in Q3 2025.